BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 20347962)

  • 1. The human area postrema and other nuclei related to the emetic reflex express cAMP phosphodiesterases 4B and 4D.
    Mori F; Pérez-Torres S; De Caro R; Porzionato A; Macchi V; Beleta J; Gavaldà A; Palacios JM; Mengod G
    J Chem Neuroanat; 2010 Sep; 40(1):36-42. PubMed ID: 20347962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential distribution of PDE4D splice variant mRNAs in rat brain suggests association with specific pathways and presynaptical localization.
    Miró X; Pérez-Torres S; Puigdomènech P; Palacios JM; Mengod G
    Synapse; 2002 Sep; 45(4):259-69. PubMed ID: 12125047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of distinct cyclic AMP-specific phosphodiesterase (phosphodiesterase type 4) isozymes in human monocytic cells.
    Verghese MW; McConnell RT; Lenhard JM; Hamacher L; Jin SL
    Mol Pharmacol; 1995 Jun; 47(6):1164-71. PubMed ID: 7603456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged beta adrenoceptor stimulation up-regulates cAMP phosphodiesterase activity in human monocytes by increasing mRNA and protein for phosphodiesterases 4A and 4B.
    Manning CD; McLaughlin MM; Livi GP; Cieslinski LB; Torphy TJ; Barnette MS
    J Pharmacol Exp Ther; 1996 Feb; 276(2):810-8. PubMed ID: 8632354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential distribution of cAMP-specific phosphodiesterase 7A mRNA in rat brain and peripheral organs.
    Miró X; Pérez-Torres S; Palacios JM; Puigdomènech P; Mengod G
    Synapse; 2001 Jun; 40(3):201-14. PubMed ID: 11304758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of cyclic nucleotide phosphodiesterases 4 in developing rat lung.
    Lopez E; Jarreau PH; Zana E; Franco-Montoya ML; Schmitz T; Evain-Brion D; Bourbon J; Delacourt C; Méhats C
    Dev Dyn; 2010 Sep; 239(9):2470-8. PubMed ID: 20652950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphodiesterase type 4 isozymes expression in human brain examined by in situ hybridization histochemistry and[3H]rolipram binding autoradiography. Comparison with monkey and rat brain.
    Pérez-Torres S; Miró X; Palacios JM; Cortés R; Puigdoménech P; Mengod G
    J Chem Neuroanat; 2000 Dec; 20(3-4):349-74. PubMed ID: 11207431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of PDE3B augments PDE4 inhibitor-induced apoptosis in a subset of patients with chronic lymphocytic leukemia.
    Moon E; Lee R; Near R; Weintraub L; Wolda S; Lerner A
    Clin Cancer Res; 2002 Feb; 8(2):589-95. PubMed ID: 11839681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of human inflammatory cell function by subtype-selective PDE4 inhibitors correlates with inhibition of PDE4A and PDE4B.
    Manning CD; Burman M; Christensen SB; Cieslinski LB; Essayan DM; Grous M; Torphy TJ; Barnette MS
    Br J Pharmacol; 1999 Dec; 128(7):1393-8. PubMed ID: 10602317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of phosphodiesterase-4 isoforms in the medulla and nodose ganglion of the squirrel monkey.
    Lamontagne S; Meadows E; Luk P; Normandin D; Muise E; Boulet L; Pon DJ; Robichaud A; Robertson GS; Metters KM; Nantel F
    Brain Res; 2001 Nov; 920(1-2):84-96. PubMed ID: 11716814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PDE4B5, a novel, super-short, brain-specific cAMP phosphodiesterase-4 variant whose isoform-specifying N-terminal region is identical to that of cAMP phosphodiesterase-4D6 (PDE4D6).
    Cheung YF; Kan Z; Garrett-Engele P; Gall I; Murdoch H; Baillie GS; Camargo LM; Johnson JM; Houslay MD; Castle JC
    J Pharmacol Exp Ther; 2007 Aug; 322(2):600-9. PubMed ID: 17519386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ciclamilast, a new PDE 4 PDE4 inhibitor, on airway hyperresponsiveness, PDE4D expression and airway inflammation in a murine model of asthma.
    Deng YM; Xie QM; Tang HF; Sun JG; Deng JF; Chen JQ; Yang SY
    Eur J Pharmacol; 2006 Oct; 547(1-3):125-35. PubMed ID: 16956605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuronal expression of cAMP-specific phosphodiesterase 7B mRNA in the rat brain.
    Reyes-Irisarri E; Pérez-Torres S; Mengod G
    Neuroscience; 2005; 132(4):1173-85. PubMed ID: 15857719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-inflammatory and utero-relaxant effects in human myometrium of new generation phosphodiesterase 4 inhibitors.
    Oger S; Méhats C; Barnette MS; Ferré F; Cabrol D; Leroy MJ
    Biol Reprod; 2004 Feb; 70(2):458-64. PubMed ID: 14561639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The differential impact of PDE4 subtypes in human lung fibroblasts on cytokine-induced proliferation and myofibroblast conversion.
    Selige J; Hatzelmann A; Dunkern T
    J Cell Physiol; 2011 Aug; 226(8):1970-80. PubMed ID: 21520048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of pregnancy on PDE4 cAMP-specific phosphodiesterase messenger ribonucleic acid expression in human myometrium.
    Leroy MJ; Méhats C; Duc-Goiran P; Tanguy G; Robert B; Dallot E; Mignot TM; Grangé G; Ferré F
    Cell Signal; 1999 Jan; 11(1):31-7. PubMed ID: 10206342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A role for cyclic nucleotide phosphodiesterase 4 in regulation of the growth of human malignant melanoma cells.
    Narita M; Murata T; Shimizu K; Nakagawa T; Sugiyama T; Inui M; Hiramoto K; Tagawa T
    Oncol Rep; 2007 May; 17(5):1133-9. PubMed ID: 17390056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression and regulation of the cAMP-selective phosphodiesterase type 4A splice variants in rat brain by chronic antidepressant administration.
    D'Sa C; Eisch AJ; Bolger GB; Duman RS
    Eur J Neurosci; 2005 Sep; 22(6):1463-75. PubMed ID: 16190900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the cAMP-phosphodiesterase PDE4D isoforms and age-related changes in follicle-stimulating hormone-stimulated PDE4 activities in immature rat sertoli cells.
    Levallet G; Levallet J; Bouraïma-Lelong H; Bonnamy PJ
    Biol Reprod; 2007 May; 76(5):794-803. PubMed ID: 17215491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 4 cAMP phosphodiesterase (PDE4) inhibitors augment glucocorticoid-mediated apoptosis in B cell chronic lymphocytic leukemia (B-CLL) in the absence of exogenous adenylyl cyclase stimulation.
    Tiwari S; Dong H; Kim EJ; Weintraub L; Epstein PM; Lerner A
    Biochem Pharmacol; 2005 Feb; 69(3):473-83. PubMed ID: 15652238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.